These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1357650)

  • 21. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
    Ziai MR; Imberti L; Tongson A; Ferrone S
    Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons.
    Giacomini P; Gambari R; Barbieri R; Nisticò P; Tecce R; Pestka S; Gustafsson K; Natali PG; Fisher PB
    Anticancer Res; 1986; 6(5):877-84. PubMed ID: 2432832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression.
    Wang Z; Margulies L; Hicklin DJ; Ferrone S
    Tissue Antigens; 1996 May; 47(5):382-90. PubMed ID: 8795138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoic acid-stimulated intercellular adhesion molecule-1 expression on SK-N-SH cells: calcium/calmodulin-dependent pathway.
    Bouillon M; Audette M
    Cancer Res; 1994 Aug; 54(15):4144-9. PubMed ID: 7913411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth inhibition and modulation of antigenic phenotype in human melanoma and glioblastoma multiforme cells by caffeic acid phenethyl ester (CAPE).
    Guarini L; Su ZZ; Zucker S; Lin J; Grunberger D; Fisher PB
    Cell Mol Biol; 1992 Aug; 38(5):513-27. PubMed ID: 1281753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules.
    Yue FY; Dummer R; Geertsen R; Hofbauer G; Laine E; Manolio S; Burg G
    Int J Cancer; 1997 May; 71(4):630-7. PubMed ID: 9178819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype.
    Garbe C; Krasagakis K; Zouboulis CC; Schröder K; Krüger S; Stadler R; Orfanos CE
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):231S-237S. PubMed ID: 2124247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon.
    Abril E; Mendez RE; García A; Serrano A; Cabrera T; Garrido F; Ruiz-Cabello F
    Tissue Antigens; 1996 May; 47(5):391-8. PubMed ID: 8795139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of protein kinase C during interferon-gamma- and phorbol ester-stimulated immunocytochemical expression of ICAM-1 in human renal carcinoma cells.
    Hansen AB; Bouchelouche PN; Giese BN; Andersen CB
    APMIS; 1993 Jun; 101(6):437-48. PubMed ID: 8103344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-beta and -gamma, but not tumor necrosis factor-alpha, demonstrate immunoregulatory effects on carcinoma cell lines infected with human papillomavirus.
    Bornstein J; Lahat N; Kinarty A; Revel M; Abramovici H; Shapiro S
    Cancer; 1997 Mar; 79(5):924-34. PubMed ID: 9041155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The modulation of class I and class II MHC molecules on intestinal epithelial cells at different stages of differentiation.
    Donnet-Hughes A; Borel Y; Schiffrin EJ
    Adv Exp Med Biol; 1995; 371A():247-9. PubMed ID: 8525918
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL1-beta, rTNF-alpha, rIFN-gamma, rIL4 and their combinations.
    Mortarini R; Belli F; Parmiani G; Anichini A
    Int J Cancer; 1990 Feb; 45(2):334-41. PubMed ID: 1689276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules.
    Darley R; Morris A; Passas J; Bateman W
    Cancer Immunol Immunother; 1993 Jul; 37(2):112-8. PubMed ID: 8100485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.
    Houghton AN; Thomson TM; Gross D; Oettgen HF; Old LJ
    J Exp Med; 1984 Jul; 160(1):255-69. PubMed ID: 6204001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXM1 expression mediates growth suppression during terminal differentiation of HO-1 human metastatic melanoma cells.
    Huynh KM; Soh JW; Dash R; Sarkar D; Fisher PB; Kang D
    J Cell Physiol; 2011 Jan; 226(1):194-204. PubMed ID: 20658516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
    Hoon DS; Banez M; Okun E; Morton DL; Irie RF
    Cancer Res; 1991 Apr; 51(8):2002-8. PubMed ID: 1901239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning of an interferon-gamma regulated human melanoma-associated antigen: identity to the intercellular adhesion molecule ICAM-1.
    Hayoz D; Rimoldi D; Kühn L; Mach JP; Carrel S
    Melanoma Res; 1991; 1(4):251-9. PubMed ID: 1688067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of recombinant fibroblast interferon and recombinant immune interferon on growth and the antigenic phenotype of multidrug-resistant human glioblastoma multiforme cells.
    Reddy PG; Graham GM; Datta S; Guarini L; Moulton TA; Jiang HP; Gottesman MM; Ferrone S; Fisher PB
    J Natl Cancer Inst; 1991 Sep; 83(18):1307-15. PubMed ID: 1653364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
    Shaw AR; Chan JK; Reid S; Seehafer J
    J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation by cytokines of HLA antigens, intercellular adhesion molecule 1 and high molecular weight melanoma associated antigen expression and of immune lysis of clones derived from the melanoma cell line MeM 50-10.
    Maio M; Gulwani B; Tombesi S; Ferrone S
    Cancer Immunol Immunother; 1989; 30(1):34-42. PubMed ID: 2513111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.